z-logo
Premium
Diabetes mellitus impairs CD133 + progenitor cell function after myocardial infarction
Author(s) -
Vöö S.,
Dunaeva M.,
Eggermann J.,
Stadler N.,
Waltenberger J.
Publication year - 2009
Publication title -
journal of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.625
H-Index - 160
eISSN - 1365-2796
pISSN - 0954-6820
DOI - 10.1111/j.1365-2796.2008.02011.x
Subject(s) - medicine , myocardial infarction , progenitor cell , diabetes mellitus , cardiology , coronary artery disease , type 2 diabetes mellitus , endothelial progenitor cell , stem cell , endocrinology , biology , genetics
. Background.  Circulating progenitor cells (PC) can positively influence the healing of ischaemic myocardium. Cardiovascular risk factors including diabetes mellitus (DM) may have a negative influence on both number and recruitment of PC. Recent evidence suggests that less differentiated CD133 + PC contribute to myocardial healing and are promising candidates for therapy. Therefore, we investigated whether DM affects CD133 + PC. Methods.  CD133 + PC were analyzed in patients following acute myocardial infarction and successful reperfusion [acute myocardial infarction (AMI, n  = 45) with/without non‐insulin‐requiring type 2 DM (T2DM)]. Stable coronary artery disease patients (CAD, n  = 45) served as stable controls. Number and phenotype of CD133 + PC were assessed by flow cytometry. CD133 + PC chemotaxis was assessed towards vascular endothelial growth factor, an angiogenic stimulus upregulated in AMI. The expression of anti‐oxidant enzymes in CD133 + PC was detected by reverse‐transcriptase PCR. Results.  In non‐DM patients, the number of CD133 + PC increased on day 3 following AMI ( P  = 0.0001). In contrast, no changes were observed in AMI patients with T2DM. Regarding the function of CD133 + PC, an enhanced chemotactic response was observed following AMI in both non‐DM ( P  = 0.0001) and T2DM ( P  = 0.007). However, the AMI‐related functional activation was significantly weaker in diabetic patients ( P  = 0.001). Moreover, the expression of catalase was lower in CD133 + PC from T2DM. Conclusions.  Our results show that T2DM not only limits the abundance of CD133 + PC following AMI, but also limits their activation. This might be explained by a lower resistance of CD133 + PC to oxidative stress. Our data provide a possible explanation for the delayed postischaemic vascular healing and myocardial recovery in DM.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here